Precision medicine is emerging as a key approach for disease treatment and prevention, which makes it even more critical to get the right medicine to the right patients. The Pharma industry is often challenged with having accurate digital data on the doctors and the organizations they work for. Times are changing, though, and with [...]
The coronavirus has forced industry to change gear, change how it communicates and, above all, change its perspective. Despite the earth- shattering turbulence of COVID-19, however, positive lessons and practices will emerge. Modern healthcare is experiencing an era-defining chapter, as international systems adjust to the very specific needs of their host countries, while also [...]
Over the past few years, our digital world has moulded a new kind of patient – engaged and empowered individuals who want to be actively involved in their health journey. With access to different treatment paths and complementary approaches based on location, physician, insurance, funds and more, therapies are becoming more personalized than ever [...]
Whether you’re looking for effective solutions to transition F2F meetings to a virtual or online environment, support with clinical trials, medical advisory boards, symposia, key opinion leader (KOL) management, internal medical training, medical writing or speaker training programs and more, count on our 15-year experience and expertise over 40 [...]
As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digital-native brands. Companies like prescription glasses firm Warby Parker, shoe brand Rothy’s and teledentistry SmileDirectClub have grown up in today’s digital-native environment and can offer some key pointers for pharma. Unlike the consumer goods [...]
Delayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic consequences for the development of their promising pipeline candidates. When data delivery lags behind the pace of a clinical study it means that data entry will be delayed – especially if the data arrives in multiple [...]
How Covid-19 could lead to pharma to examine and change how clinical trials operate. In light of the global pandemic, Pharma is having to strategically re-evaluate their R&D pipelines and decide whether or not planned clinical trials can go ahead in existing timeframes and if existing trials can continue in their current scope of [...]
Carolyn Whiting - SDM's Executive Vice President, Strategy & Innovation - was interviewed by Illumina Interactive Learning. We’ve all witnessed profound and swift changes to our lives and to our businesses due to the pandemic. But one thing we’ve seen is that the need for communication and learning has continued – and in some [...]
Big Pharma companies are often criticized for trying to make the world too reliant on their products. There are also many who oppose the idea of a mandatory vaccine against COVID-19. But the bottom line is that it is up to these companies to restore a new normal by battling and protecting the world [...]
The roots and history of the pharmaceutical industry lie back with the apothecaries and pharmacies that offered traditional remedies as far back as the middle ages, offering a hit-and-miss range of treatments based on centuries of folk knowledge. But the industry as we understand it today really has its origins in the second half [...]